5-氮杂-2'-脱氧胞苷和曲古抑菌素A对卵巢癌顺铂耐药细胞中hMLH1表达及DNA甲基化的影响  

Effects of 5-Aza-2'-deoxycytidine and Trichostatin A on DNA Methylation and Expression of hMLH1 in Ovarian Cancer Cell Line COC1/DDP

作　　者：孟春风[1] 戴冬秋[1] 郭科军[2] 

机构地区：[1]中国医科大学附属第一医院肿瘤外科普通外科教研室,辽宁沈阳110001 [2]中国医科大学附属第一医院妇科,辽宁沈阳110001

出　　处：《癌症》2008年第12期1251-1255,共5页Chinese Journal of Cancer

摘　　要：背景与目的:顺铂能造成细胞内DNA的损伤,而DNA错配修复蛋白能发现顺铂导致的DNA损伤,产生损伤信号,诱导细胞凋亡,从而摧毁肿瘤细胞。hMLH1是DNA错配修复系统的一个重要成员,其缺失能导致肿瘤对顺铂的耐受。本研究目的在于探讨卵巢癌顺铂耐药细胞中hMLH1表达及其基因启动子区DNA甲基化状态,同时探讨去甲基化制剂—5-氮杂-2'-脱氧胞苷(5-aza-2'——deoxycytidine,5-Aza-dC)和组蛋白脱乙酰化酶抑制剂——曲古抑菌素A(trichostatin A,TSA)对hMLH1表达及DNA甲基化的逆转作用。方法:应用5-Aza-dC和TSA作用于卵巢癌细胞COC1与其顺铂耐药细胞COC1/DDP,应用甲基化特异性PCR、RT-PCR和Western blot检测上述两种细胞中hMLH1基因启动子区DNA甲基化、hMLH1 mRNA和hMLH1蛋白表达的变化。MTT法检测药物对细胞增殖的影响。结果:COC1细胞存在hMLH1 mRNA和蛋白的表达,其启动子区域表现为DNA非甲基化。单独应用5-Aza-dC、TSA及联合应用5-Aza-dC和TSA对COC1细胞中hMLH1 mRNA、hMLH1蛋白表达和DNA甲基化均没有影响(P>0.05),细胞形态变化不明显。COC1/DDP细胞中hMLH1 mRNA和蛋白表达缺失,启动子区域表现为DNA甲基化。5-Aza-dC不但能使COC1/DDP细胞中hMLH1基因发生DNA去甲基化,而且能使表达缺失的hMLH1 mRNA和hMLH1蛋白重新表达。TSA对COC1/DDP细胞中hMLH1 mRNA、hMLH1蛋白表达和DNA甲基化均没有影响(P>0.05)。联合应用5-Aza-dC和TSA不但能使hMLH1基因发生DNA去甲基化,而且与单独应用5-Aza-dC相比较,对hMLH1 mRNA和hMLH1蛋白表达的影响更明显(P<0.05)。5-Aza-dC单用及联合应用TSA对COC1/DDP细胞生长抑制率明显高于COC1组、阴性对照组(P<0.05)。结论:COC1/DDP细胞对顺铂的耐药性与hMLH1mRNA和蛋白的表达缺失有关,而hMLH1基因和蛋白的表达缺失与其基因启动子区DNA甲基化相关,5-Aza-dC单用及联合TSA使hMLH1基因发生DNA去甲基化,促进hMLH1的表达,逆转COC1/DDP细胞对DDP的耐药�BACKGROUND ＆ OBJECTIVE Cisplatin （DDP） can cause DNA damage in cells. DNA mismatch repair proteins serve to detect DDP caused DNA damage and generate an injury signal that eventually contributes to the triggering of tumor cell apoptosis. As a member of the mismatch repair system, the absence of hMLH1 expression contributes to the resistance of tumor cells to DDP. This study was to explore the role of hMLH1 expression and DNA methylation in DDP-resistance of human ovarian cancer, and to evaluate the reversal effects of 5-aza-2＇-deoxycytidine （5-Aza-dC） and trichostatin A （TSA） on DDP-resistance. METHODS= We cultured human ovarian cancer cell line COC1 and its DDP-resistant subline, COC1/DDP. We treated the two cell lines with 5-Aza-dC and TSA. DNA methylation at hMLH1 gene promoter was detected by methylation-specific polymerase chain reaction （MSP）. The expression of hMLH1 was detected by reverse transcriptionpolymerase chain reaction （RT-PCR） and Western blot. The inhibition rate of cell.proliferation was detected by MTI- assay. RESULTS： In COC1 cells, both hMLH1 mRNA and protein were detected, while no DNA methylation of hMLH1 gene was detected. 5-Aza-dC and TSA used alone or in combination had no effects on DNA methylation, hMLH1 mRNA or protein expression （P〉 0.05）, and cell proliferation. In COC1/DDP cells, DNA hypermethylation of hMLH1 gene was detected, while no hMLH1 mRNA or protein was detected. 5-Aza-dC resulted in DNA demethylation and restoration of hMLH1 expression. TSA had no effect on DNA demethylation or restoration of hMLH1 expression. 5-Aza-dC plus TSA also resulted in DNA demethylation, restored hMLH1 expression more obviously than 5-Aza-dC did （P〈0.05）, and restricted the proliferation of COC1/DDP cells. CONCLUSIONS： Hypermethylation of DNA promoter is related to the silencing of hMLH1 in ovarian cancer COC1/DDP cells. 5-Aza-dC alone or in combination with TSA results in DNA demethylation of hMLH1 gene, restoration of hMLH1 expression and reversal of DDP

关 键 词：卵巢肿瘤 COC1细胞 顺铂 耐药细胞 DNA甲基化 hMLH1 5-氮杂-2’-脱氧胞苷 曲古抑菌素A 

分 类 号：R737.31[医药卫生—肿瘤]